(Q36071037)

12 August 2017

1 reference

title

Overview of vaccines and vaccination (English)

1 reference

12 August 2017

1

Gordon Ada

1 reference

12 August 2017

publication date

1 March 2005

1 reference

12 August 2017

published in

Molecular Biotechnology

1 reference

12 August 2017

volume

29

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

255-272

1 reference

https://scigraph.springernature.com/pub.10.1385/mb:29:3:255

12 August 2017

exact match

0 references

1 reference

12 December 2020

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

12 December 2020

The immune system. First of two parts

1 reference

12 December 2020

Intussusception among infants given an oral rotavirus vaccine

1 reference

12 December 2020

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

1 reference

12 December 2020

Adjuvant formulations for experimental vaccines

1 reference

12 December 2020

Regulation of host immune responses by modification of Salmonella virulence genes.

1 reference

12 December 2020

Live viral vectors: vaccinia virus

1 reference

12 December 2020

Efficacy trial of malaria vaccine SPf66 in Gambian infants

1 reference

12 December 2020

An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines

1 reference

12 December 2020

Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program

1 reference

12 December 2020

Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update.

1 reference

12 December 2020

Transcutaneous immunization: a human vaccine delivery strategy using a patch

1 reference

12 December 2020

Increased mortality after high titer measles vaccines: too much of a good thing.

1 reference

12 December 2020

Genetic detoxification of bacterial toxins

1 reference

12 December 2020

The challenge of emerging and re-emerging infectious diseases

1 reference

12 December 2020

1 reference

12 December 2020

Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

1 reference

12 December 2020

MMR vaccine: the continuing saga

1 reference

12 December 2020

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

12 December 2020

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization

1 reference

12 December 2020

Indications and contraindications for vaccines used in the Expanded Programme on Immunization

1 reference

12 December 2020

Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection

1 reference

12 December 2020

Edible vaccines not ready for main course

1 reference

12 December 2020

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS.

1 reference

12 December 2020

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

1 reference

12 December 2020

Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo

1 reference

12 December 2020

Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo

1 reference

12 December 2020

The cellular basis for lack of antibody response to hepatitis B vaccine in humans

1 reference

12 December 2020

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network

1 reference

12 December 2020

AIDS vaccines. HIV dodges one-two punch

1 reference

12 December 2020

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

1 reference

12 December 2020

Live viral vectors: construction of a replication-deficient recombinant adenovirus

1 reference

12 December 2020

Current status of live attenuated influenza virus vaccine in the US.

1 reference

12 December 2020

The use of complete genome sequences in vaccine design

1 reference

12 December 2020

A biological role for the major histocompatibility antigens

1 reference

12 December 2020

Guns, germs and steel: A short history of everybody for the last 13, 000 years

1 reference

12 December 2020

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

1 reference

12 December 2020

Overview: the many uses and applications of transgenic plants.

1 reference

12 December 2020

Vaccines and vaccination

1 reference

12 December 2020

Unravelling the mysteries of molecular audit: MHC class I restriction

1 reference

12 December 2020

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

1 reference

12 December 2020

Cytotoxic T cells recognize very early, minor changes in ectromelia virus-infected target cells

1 reference

12 December 2020

Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci

1 reference

12 December 2020

Identifiers

DOI

10.1385/MB:29:3:255

1 reference

Dimensions Publication ID

12 August 2017

1021934151

0 references

1 reference